Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

2.360 UNCHANGED
Streaming Delayed Price Updated: 12:32 PM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results
Via Investor Brand Network
Why InMed Pharmaceuticals Stock Is Soaring Tuesday
InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading higher Tuesday after the company said it selected a lead Alzheimer's drug candidate following positive proof-of-concept study data.  
Via Benzinga
Dow Surges 250 Points; US Manufacturing PMI Tops Expectations
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 250 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.80% to 33,200.75 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference
InMed Pharmaceuticals (NASDAQ: INM) is a global leader in researching, developing, manufacturing and commercializing rare cannabinoids and cannabinoid analogs. 
Via Benzinga
Topics Cannabis
Cannabis Industry Report Highlights Positive Sentiment and Growth Potential at Benzinga Conference
Discover key insights from the Benzinga Cannabis Conference, featuring strategies from top firms like MariMed, AYR & InMed! 
Via Benzinga
Topics Cannabis
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate Update
Via Investor Brand Network
This Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness Sector
BayMedica, a rare cannabinoids supplier for the health and wellness sector acquired by InMed Pharmaceuticals (NASDAQ: INM) in 2021, is scaling up its manufacturing process to meet growing demand. 
Via Benzinga
Topics Supply Chain
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference
Via Investor Brand Network
Cannabis Stock Gainers And Losers From August 25, 2023
 
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From July 25, 2023
 
Via Benzinga
Marijuana Stock Movers For August 22, 2023
 
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For July 21, 2023
 
Via Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
Via CannabisNewsWire
Topics Supply Chain
Marijuana Stock Movers For August 15, 2023
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
Via Investor Brand Network
Topics Supply Chain
Cannabis Stock Gainers And Losers From August 11, 2023
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
Via CannabisNewsWire
Topics Supply Chain
Cannabis Stock Movers For August 10, 2023
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
Via Investor Brand Network
Topics Supply Chain
Marijuana Stock Movers For August 8, 2023
 
Via Benzinga
Game-Changer In Epidermolysis Bullosa Treatment? Cannabis Compound Holds Promise
In a positive step for the treatment of the rare genetic dermatological condition known as epidermolysis bullosa (EB), InMed Pharmaceuticals Inc. (NASDAQ: INM) has published top-line data from its... 
Via Benzinga
Marijuana Stock Movers For August 1, 2023
 
Via Benzinga
Why Are InMed Pharmaceuticals Stock Trading Lower Today
InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading lower after the company released safety and efficacy results from its Phase 2 clinical trial (755-201-EB) for  
Via Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results
Via Investor Brand Network
Cannabis Stock Movers For July 24, 2023
 
Via Benzinga
Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment
The study focused on the potential of rare cannabinoids in the treatment of neurodegenerative diseases like Alzheimer's. According to the researchers behind the study, this breakthrough research opens... 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at Canadian Neuroscience Meeting
Via CannabisNewsWire
Cannabis Stock Movers For July 20, 2023
 
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.